Pro­to­cols: Boom­ing Mod­er­na adds staff, new clin­i­cal pro­gram; Lil­ly boasts of R&D gains

As promised, fast-grow­ing Mod­er­na has moved its sec­ond pro­gram in­to clin­i­cal de­vel­op­ment. The mR­NA spe­cial­ist now has mR­NA 1440 and mR­NA 1851, in­fec­tious dis­ease vac­cine …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER